1.Effect of ginkgolide B on platelet-activating factor induced activation of rat polymorphonuclear leukocytes.
Acta Pharmaceutica Sinica 2003;38(2):98-102
AIMTo investigate the effect of ginkgolide B on PAF-induced adhesion, chemotaxis and degranulation of rat polymorphonuclear leukocytes (PMNs).
METHODSThe adhesion of rat PMNs to rat synovial cells (RSC) was measured with MTT colorimetry. The chemotaxis of PMNs was quantified with Boyden chamber method. The degranulation of rat PMNs was evaluated by determining the activity of released beta-glucuronidase.
RESULTSIn comparison with control, ginkgolide B at the concentration of 10 mumol.L-1 significantly inhibited the adhesion of PMNs to RSC by 71.74%. At the final concentration of 1-1,000 nmol.L-1, ginkgolide B dose-dependently inhibited the chemotaxis of PMNs stimulated with 10 nmol.L-1 platelet-activating factor (PAF), the IC50 was 4.84 nmol.L-1. At the final concentration of 0.01-10 mumol.L-1, ginkgolide B decreased the release of beta-glucuronidase in PMNs induced by 1 mumol.L-1 PAF in dose-dependent manner. The IC50 was 3.56 mumol.L-1.
CONCLUSIONGinkgolide B was found to significantly inhibit PAF-induced adhesion, chemotaxis and degranulation in rat polymorphonuclear leukocytes. These effects might be considered a part of the mechanisms underlying the antiinflammatory action of ginkgolide B.
Animals ; Anti-Inflammatory Agents, Non-Steroidal ; pharmacology ; Cell Adhesion ; drug effects ; Cells, Cultured ; Chemotaxis, Leukocyte ; drug effects ; Diterpenes ; isolation & purification ; pharmacology ; Drug Interactions ; Ginkgo biloba ; chemistry ; Ginkgolides ; Glucuronidase ; metabolism ; Lactones ; isolation & purification ; pharmacology ; Male ; Neutrophils ; drug effects ; physiology ; Plants, Medicinal ; chemistry ; Platelet Activating Factor ; antagonists & inhibitors ; pharmacology ; Rats ; Rats, Wistar
2.Effects of ginkgolide B on lipopolysaccharide-induced TNFalpha production in mouse peritoneal macrophages and NF-kappaB activation in rat pleural polymorphonuclear leukocytes.
Zhen-gui NIE ; Shan-ying PENG ; Wen-jie WANG
Acta Pharmaceutica Sinica 2004;39(6):415-418
AIMTo study the effects of ginkgolide B on lipopolysaccharide (LPS)--induced TNFalpha production in mouse peritoneal macrophages and NF-kappaB activation in rat pleural polymorphonuclear leukocytes.
METHODSL929 crystal violet staining assay was used to show the level of TNFalpha released from mouse peritoneal macrophages induced by LPS. Electrophoretic mobility shift assay (EMSA) was used to determine NF-kappaB binding activities.
RESULTSGinkgolide B (1, 10 micromol x L(-1)) was shown to significantly inhibit LPS (10 mg x L(-1))-induced TNFalpha production in mouse peritoneal macrophages, the IC50 was 0.26 micromol x L(-1); LPS (1 mg x L(-1)) and PAF (1 nmol , L(-1)) were shown to increase the NF-kappaB binding activities in rat pleural polymorphonuclear leukocytes; ginkgolide B (10 micromol x L(-1)) was found to inhibit LPS (1 mg x L(-1))-induced NF-kappaB activation in rat pleural polymorphonuclear leukocytes; ginkgolide B (1, 10 micromol x L(-1)) was shown to inhibit PAF (1 nmol x L(-1))-induced NF-kappaB activation in rat pleural polymorphonuclear leukocytes.
CONCLUSIONThe inhibition of NF-kappaB activation and TNFalpha production might be considered to be part of the mechanisms underlying the antiinflammatory action of ginkgolide B; PAF is involved in activation of the NF-kappaB pathway stimulated with LPS.
Animals ; Anti-Inflammatory Agents, Non-Steroidal ; pharmacology ; Diterpenes ; isolation & purification ; pharmacology ; Female ; Ginkgo biloba ; chemistry ; Ginkgolides ; Lactones ; isolation & purification ; pharmacology ; Lipopolysaccharides ; antagonists & inhibitors ; Macrophages, Peritoneal ; metabolism ; Male ; Mice ; Mice, Inbred C57BL ; NF-kappa B ; metabolism ; Neutrophils ; enzymology ; Plants, Medicinal ; chemistry ; Platelet Activating Factor ; antagonists & inhibitors ; Rats ; Rats, Wistar ; Tumor Necrosis Factor-alpha ; biosynthesis
3.Rupture-A symbolic timing point of the natural abdominal rupture during cadaver decay
Xingchun ZHAO ; Fan YANG ; Sheng HU ; Hao NIE ; Jiajia FAN ; Zhen PENG ; Gengqian ZHANG ; Peng GUI ; Zengtao ZHONG
Chinese Journal of Forensic Medicine 2024;39(1):68-74
Objective Corruption is the most common cadaver phenomenon in forensic practice and an important basis for inferring time of death(PMI),but the definition of corruption degree and the construction of model inference models have always been difficult in the practice of forensic science.Methods In this study,the late postmortem phenomena were observed.Meanwhile,the microbial flora structure of gut and gravesoil and the nature of gravesoil were detected,for analyzing the changes before and after the key moment of abdominal rupture which naturally happened during the cadaver decay.Results The results found that from the macroscopic and microscopic levels,there were significant differences in cadaver decay,including microbial flora structure and gravesoil properties before and after the key moment of the natural abdominal rupture during cadaver decay.The phenomena are highly observable and can be accurately judged by forensic examinations,as well as related means in the field of biology and physiochemistry.In this study,this critical event was called Rupture Point.Conclusion The Rupture Point can be used as an important node for the assessment of cadaver decay degree in the practice of forensic medicine.It can be utilized for a cut-off point as well when constructing PMI inference models based on microbial flora structure changes.The accuracy of PMI inference models can be improved when the models were constructed in segments.
4.Synthesis and antiinflammation activity of aromatic aminoketone compounds, a new type of PAF-receptor antagonist.
Li-yuan MOU ; Zi-yun LIN ; Jie LIU ; Qi-dong ZHANG ; Li-ya ZHU ; Wen-jie WANG ; Zhen-gui NIE ; Yu HE
Acta Pharmaceutica Sinica 2008;43(9):917-925
A series of aromatic aminoketones were synthesized by Mannich reaction. Structures of these compounds were confirmed by 1H NMR, MS and HRMS or element analysis. Pharmacological screening showed that most target compounds inhibited the release of beta-glucuronidase in polymorphonuclear leucocytes by PAF (platelet activating factor) and compounds MA12, MA13, MA18, MA21 and MA33 were more active. The study suggests that target compounds are potential PAF receptor antagonists and their anti-inflammatory activities are due to the inhibition of release of lysosomal enzyme.
Animals
;
Anti-Inflammatory Agents
;
chemical synthesis
;
chemistry
;
pharmacology
;
therapeutic use
;
Arthritis, Rheumatoid
;
drug therapy
;
Glucuronidase
;
metabolism
;
Ketones
;
chemical synthesis
;
chemistry
;
pharmacology
;
therapeutic use
;
Macrophages, Peritoneal
;
metabolism
;
Mice
;
Neutrophils
;
enzymology
;
Platelet Membrane Glycoproteins
;
antagonists & inhibitors
;
Rats
;
Receptors, G-Protein-Coupled
;
antagonists & inhibitors
;
Structure-Activity Relationship
;
Tumor Necrosis Factor-alpha
;
biosynthesis
5.Effect of ginkgolide B on the production of NO, IL-6 and RANTES from astrocytes.
Shan-ying PENG ; Wen-hui LIAO ; Zhen-gui NIE ; Yang LIU ; Lin WANG ; Feng WANG ; Wen-jie WANG
Acta Pharmaceutica Sinica 2010;45(9):1103-1108
This study is to explore the effect of ginkgolide B (BN52021) on the production of nitric oxide (NO), interleukin (IL)-6 and regulated upon activation normal T cell expressed and secreted (RANTES) from astrocytes induced by stimulators. Primary cultured rat astrocytes were stimulated with lipopolysaccharides (LPS), the production of NO was assayed using Griess reaction; U251 cells were stimulated with IL-1 beta, the contents of IL-6 and RANTES in the supernatant were measured using ELISA. The mRNA expressions of IL-6 and RANTES were detected using RT-PCR. LPS (10 ng mL(-1) to 10 microg mL(-1)) could stimulate rat astrocytes to produce NO in a dose-dependent manner. Ginkgolide B at the concentrations of 0.1-10 micromol L(-1) were shown to decrease NO production significantly. IL-1 beta could induce the mRNA expression and protein secretion of IL-6 from U251 cells, as well as RANTES. Ginkgolide B at concentrations of 0.1-10 micromol L(-1) were shown to inhibit RANTES secretion, and to inhibit mRNA expression of IL-6 and RANTES at concentration of 10 micromol L(-1). Ginkgolide B has inhibitory effect on the production of NO, IL-6 and RANTES from astrocytes treated with inflammatory stimulators.
Animals
;
Astrocytes
;
cytology
;
metabolism
;
Cell Line, Tumor
;
Cells, Cultured
;
Chemokine CCL5
;
genetics
;
metabolism
;
Dose-Response Relationship, Drug
;
Ginkgolides
;
administration & dosage
;
pharmacology
;
Glioblastoma
;
metabolism
;
pathology
;
Humans
;
Interleukin-1beta
;
Interleukin-6
;
genetics
;
secretion
;
Lactones
;
administration & dosage
;
pharmacology
;
Lipopolysaccharides
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Nitric Oxide
;
metabolism
;
Platelet Activating Factor
;
antagonists & inhibitors
;
RNA, Messenger
;
metabolism
;
Rats
;
Rats, Wistar